Firdapse

Chemical Nameamifampridine
Dosage FormTablet (oral; 10 mg)
Drug ClassChannel blockers
SystemNervous
CompanyCatalyst Pharmaceuticals
Approval Year2018

Indication

  • To treat Lambert-Eaton myasthenic syndrome in adults.
Last updated on 11/4/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Firdapse (Amifampridine) Prescribing Information2018Catalyst Pharmaceuticals, Coral Gables, FL